
New method allows tracking of HIV
According to study leaders Prof. Christian Eggeling from Leibniz IPHT, Dr. Cyril Favard and Dr. Delphine Muriaux from the Montpellier Infectious...

Vaximm goes East for cancer vaccine deal
T-cell immunotherapy expert Vaximm plans to use Artificial Intelligence (AI) to develop personalised cancer vaccines. The biotech is collaboration...

bit bio restarts with new management
Cambridge-based cell reprogramming specialist Elpis Biomed will be re-started under the new name bit bio with a new management and an extended...

Sherlock Bioscience and Mologic enter partnership
Mologic said it will invest a part of an expansion to its $4.9m grant from the Bill and Melinda-Gates Foundation to finance access to Sherlock's...

DPP3 triggers myocardial depression
Results of two independent studies published fast-track and presented on Saturday at ESC Congress 2019 (Paris) by Prof. Alexandre Mebazza...

€7.34m for cancer vaccine developer
Private clinical-stage biotech MaxiVAX announced that it has been awarded a European Commission grant of €2,785,000, thanks to the Horizon 2020 EIC...